These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15605444)

  • 1. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
    Bodea A; Leucuta SE
    Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate.
    Nutan MT; Soliman MS; Taha EI; Khan MA
    Int J Pharm; 2005 Apr; 294(1-2):89-101. PubMed ID: 15814233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.
    Zhu S; Hong M; Liu C; Pei Y
    Pharm Dev Technol; 2009; 14(6):642-9. PubMed ID: 19883253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the formulation parameters on the characteristics of pellets.
    Fekete R; Zelkó R; Marton S; Rácz I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing.
    Bianchini R; Vecchio C
    Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Dev Technol; 1998 Nov; 3(4):423-32. PubMed ID: 9834944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation.
    Tomuţă I; Leucuţa SE
    Acta Pol Pharm; 2012; 69(5):951-64. PubMed ID: 23061293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optima: a windows-based program for computer-aided optimization of controlled-release dosage forms.
    Lu DR; Abu-Izza K; Chen W
    Pharm Dev Technol; 1996 Dec; 1(4):405-14. PubMed ID: 9552324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of a fluid bed spray coating process using reduced factorial design.
    Johansson ME; Ringberg A; Nicklasson M
    J Microencapsul; 1987; 4(3):217-22. PubMed ID: 3504507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
    Ensslin S; Moll KP; Metz H; Otz M; Mäder K
    Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
    Leopold CS; Eikeler D
    J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.